Skip to content

RNTX RNTX Common Stock

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
CTO
Citius Oncology, Inc.CTOR
400M+300%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$98K+10.1%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$91K+4.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$9K0.0%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's common stock?
RNTX (RNTX) reported common stock of $114K in Q1 2026.
How has RNTX's common stock changed year-over-year?
RNTX's common stock increased by 5.6% year-over-year, from $108K to $114K.
What is the long-term trend for RNTX's common stock?
Over 5 years (2020 to 2025), RNTX's common stock has grown at a 20.8% compound annual growth rate (CAGR), from $44K to $113K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).